Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuchbinder, Rachelleen
dc.contributor.authorOsborne, Richard H.en
dc.contributor.authorEbeling, Peter R.en
dc.contributor.authorWark, John D.en
dc.contributor.authorMitchell, Peteren
dc.contributor.authorWriedt, Chris J.en
dc.contributor.authorGraves, Stephen Ellisen
dc.contributor.authorStaples, Margaret P.en
dc.contributor.authorMurphy, Bridieen
dc.identifier.citationNew England Journal of Medicine, 2009; 361(6):557-568en
dc.descriptionCopyright © 2009 Massachusetts Medical Society. All rights reserved.en
dc.description.abstractBackground: Vertebroplasty has become a common treatment for painful osteoporotic vertebral fractures, but there is limited evidence to support its use. Methods: We performed a multicenter, randomized, double-blind, placebo-controlled trial in which participants with one or two painful osteoporotic vertebral fractures that were of less than 12 months' duration and unhealed, as confirmed by magnetic resonance imaging, were randomly assigned to undergo vertebroplasty or a sham procedure. Participants were stratified according to treatment center, sex, and duration of symptoms (<6 weeks or ≥6 weeks). Outcomes were assessed at 1 week and at 1, 3, and 6 months. The primary outcome was overall pain (on a scale of 0 to 10, with 10 being the maximum imaginable pain) at 3 months. Results: A total of 78 participants were enrolled, and 71 (35 of 38 in the vertebroplasty group and 36 of 40 in the placebo group) completed the 6-month follow-up (91%). Vertebroplasty did not result in a significant advantage in any measured outcome at any time point. There were significant reductions in overall pain in both study groups at each follow-up assessment. At 3 months, the mean (±SD) reductions in the score for pain in the vertebroplasty and control groups were 2.6±2.9 and 1.9±3.3, respectively (adjusted between-group difference, 0.6; 95% confidence interval, –0.7 to 1.8). Similar improvements were seen in both groups with respect to pain at night and at rest, physical functioning, quality of life, and perceived improvement. Seven incident vertebral fractures (three in the vertebroplasty group and four in the placebo group) occurred during the 6-month follow-up period. Conclusions: We found no beneficial effect of vertebroplasty as compared with a sham procedure in patients with painful osteoporotic vertebral fractures, at 1 week or at 1, 3, or 6 months after treatment. (Australian New Zealand Clinical Trials Registry number, ACTRN012605000079640.)en
dc.description.statementofresponsibilityRachelle Buchbinder, Richard H. Osborne, Peter R. Ebeling, John D. Wark, Peter Mitchell, Chris Wriedt, Stephen Graves, Margaret P. Staples and Bridie Murphyen
dc.publisherMassachusetts Medical Socen
dc.titleA Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fracturesen
dc.typeJournal articleen
dc.contributor.schoolSchool of Medicineen
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.